Benzinga | Feb 10, 2021 07:24AM EST

Teva Pharmaceutical Indus Q4 EPS $0.68 Beats $0.63 Estimate, Sales $4.45B Beat $4.37B Estimate

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.63 by 7.94 percent. This is a 9.68 percent increase over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $4.45 billion which beat the analyst consensus estimate of $4.37 billion by 1.92 percent. This is a 0.31 percent decrease over sales of $4.47 billion the same period last year.